U.S. CDC expands COVID-19 vaccine eligibility to 16 and older
Reuters
Published Apr 20, 2021 02:10
(Reuters) - Everyone in United States aged 16 years and above is now eligible for COVID-19 vaccination, the U.S. Centers for Disease Control and Prevention (CDC) said on Monday.
People aged 16 years and above who have underlying medical conditions that increase the risk of serious, life-threatening complications from COVID-19, should be among those offered the vaccine first, according to the U.S. health agency's latest recommendations. (https://
Majority of U.S. states have already expanded their COVID-19 vaccine rollouts to people from this age group. Alaska was the first state to lower statewide eligibility to age 16 and was followed by states including Georgia, Texas and California.
Earlier in April, U.S. President Joe Biden had directed states to widen the vaccine eligibility to people aged 18 or above by April 19. No COVID-19 vaccine is authorized yet for those under 16, although testing is underway.
More than half of U.S. adults have received at least one COVID-19 vaccine dose, according to CDC.
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.